Literature DB >> 35418469

Promoter Proximity Defines Mutation Window for VH and VΚ Genes Rearranged to Different J Genes.

Justin H M Heltzel1, Robert W Maul1, William Yang1, Patricia J Gearhart2.   

Abstract

Somatic hypermutation induced by activation-induced deaminase (AID) occurs at high densities between the Ig V gene promoter and intronic enhancer, which encompasses DNA encoding the rearranged V gene exon and J intron. It has been proposed that proximity between the promoter and enhancer defines the boundaries of mutation in V regions. However, depending on the J gene used, the distance between the promoter and enhancer is quite variable and may result in differential targeting around the V gene. To examine the effect of distance in mutation accumulation, we sequenced 320 clones containing different endogenous rearranged V genes in the IgH and Igκ loci from Peyer's patch B cells of mice. Clones were grouped by their use of different J genes. Distances between the V gene and enhancer ranged from ∼2.3 kb of intron DNA for rearrangements using J1, ∼2.0 kb for rearrangements using J2, ∼1.6 kb for rearrangements using J3 (H) or 4 (κ), and 1.1 kb for rearrangements using J4 (H) or 5 (κ). Strikingly, >90% of intron mutations occurred within 1 kb downstream of the J gene for both H and κ clones, regardless of which J gene was used. Thus, there is no evidence that the intron sequence or enhancer plays a role in determining the extent of mutation. The results indicate that V region intron mutations are targeted by their proximity to the promoter, suggesting they result from AID interactions with RNA polymerase II over a 1-kb region.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35418469      PMCID: PMC9050841          DOI: 10.4049/jimmunol.2101002

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  59 in total

1.  Roles of the Ig kappa light chain intronic and 3' enhancers in Igk somatic hypermutation.

Authors:  Matthew A Inlay; Heather H Gao; Valerie H Odegard; Tongxiang Lin; David G Schatz; Yang Xu
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

2.  The 5' hypermutation boundary of kappa chains is independent of local and neighbouring sequences and related to the distance from the initiation of transcription.

Authors:  C Rada; J Yélamos; W Dean; C Milstein
Journal:  Eur J Immunol       Date:  1997-12       Impact factor: 5.532

3.  Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice.

Authors:  Cristina Rada; Gareth T Williams; Hilde Nilsen; Deborah E Barnes; Tomas Lindahl; Michael S Neuberger
Journal:  Curr Biol       Date:  2002-10-15       Impact factor: 10.834

4.  Antibody diversity: somatic hypermutation of rearranged VH genes.

Authors:  S Kim; M Davis; E Sinn; P Patten; L Hood
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

5.  Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region.

Authors:  A G Betz; C Milstein; A González-Fernández; R Pannell; T Larson; M S Neuberger
Journal:  Cell       Date:  1994-04-22       Impact factor: 41.582

6.  The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates.

Authors:  Uttiya Basu; Fei-Long Meng; Celia Keim; Veronika Grinstein; Evangelos Pefanis; Jennifer Eccleston; Tingting Zhang; Darienne Myers; Caitlyn R Wasserman; Duane R Wesemann; Kurt Januszyk; Richard I Gregory; Haiteng Deng; Christopher D Lima; Frederick W Alt
Journal:  Cell       Date:  2011-01-20       Impact factor: 41.582

7.  The transcriptional promoter regulates hypermutation of the antibody heavy chain locus.

Authors:  K Tumas-Brundage; T Manser
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

8.  Altered somatic hypermutation and reduced class-switch recombination in exonuclease 1-mutant mice.

Authors:  Philip D Bardwell; Caroline J Woo; Kaichun Wei; Ziqiang Li; Alberto Martin; Stephen Z Sack; Tchaiko Parris; Winfried Edelmann; Matthew D Scharff
Journal:  Nat Immunol       Date:  2004-01-11       Impact factor: 25.606

9.  Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1.

Authors:  Silvestro G Conticello; Karuna Ganesh; Kanmin Xue; Mason Lu; Cristina Rada; Michael S Neuberger
Journal:  Mol Cell       Date:  2008-08-22       Impact factor: 17.970

10.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.